Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/challenges-in-delivery-systems-for-crispr-based-genome-editing-and-Fe0FyeMzvP
References (128)
-
O Shalem (2014)
84Science, 343
-
Xiaoyun Xu, Dongbing Gao, Ping Wang, Jian Chen, Jinxue Ruan, Jie Xu, Xiaofeng Xia (2018)
Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporationScientific Reports, 8
-
L. Kick, Marion Kirchner, S. Schneider (2017)
CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trialsBioengineered, 8
-
M. Mitchell, Margaret Billingsley, Rebecca Haley, Marissa Wechsler, N. Peppas, R. Langer (2020)
Engineering precision nanoparticles for drug deliveryNature Reviews. Drug Discovery, 20
-
H Yin, W Xue, SD Chen, RL Bogorad, E Benedetti, M Grompe, V Koteliansky, PA Sharp, T Jacks, DG Anderson (2014)
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype (vol 32, pg 551, 2014)Nat Biotechnol, 32
-
P. Williams, P. Kingston (2011)
Plasmid-mediated gene therapy for cardiovascular disease.Cardiovascular research, 91 4
-
Mei-Yi Yan, Sicong Li, Xin-Yuan Ding, Xiao-Peng Guo, Q. Jin, Yi-Cheng Sun (2020)
A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosismBio, 11
-
ZH Ou, XH Niu, WY He, YC Chen, B Song, YX Xian, D Fan, DL Tang, XF Sun (2016)
The combination of CRISPR/Cas9 and iPSC technologies in the gene therapy of human beta-thalassemia in miceSci Rep-Uk, 6
-
S. Montoto, G. Muraca, M. Ruiz (2020)
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical AspectsFrontiers in Molecular Biosciences, 7
-
V. Pattanayak, C. Ramirez, J. Joung, David Liu (2011)
Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro SelectionNature methods, 8
-
P. Chapdelaine, Christophe Pichavant, J. Rousseau, F. Pâques, J. Tremblay (2010)
Meganucleases can restore the reading frame of a mutated dystrophinGene Therapy, 17
-
S. Alsaiari, S. Patil, Mram Alyami, K. Alamoudi, Fajr Aleisa, J. Merzaban, Mo Li, N. Khashab (2018)
Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework.Journal of the American Chemical Society, 140 1
-
GM Findlay (2014)
120Nature, 513
-
Weiqi Hong, Jingyun Yang, Zhenfei Bi, Cai He, H. Lei, Wenhai Yu, Yun Yang, Changfa Fan, Shuaiyao Lu, Xiaozhong Peng, Xiawei Wei (2021)
A mouse model for SARS-CoV-2-induced acute respiratory distress syndromeSignal Transduction and Targeted Therapy, 6
-
M Vilarino, ST Rashid, FP Suchy, BR McNabb, T van der Meulen, EJ Fine, S Ahsan, N Mursaliyev, V Sebastiano, SS Diab, MO Huising, H Nakauchi, PJ Ross (2017)
CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheepSci Rep-Uk, 7
-
B. Yip (2020)
Recent Advances in CRISPR/Cas9 Delivery StrategiesBiomolecules, 10
-
Narges Elahi, M. Kamali, M. Baghersad (2018)
Recent biomedical applications of gold nanoparticles: A review.Talanta, 184
-
Daniel Rosenblum, Anna Gutkin, Ranit Kedmi, S. Ramishetti, Nuphar Veiga, Ashley Jacobi, Mollie Schubert, D. Friedmann-Morvinski, Z. Cohen, M. Behlke, J. Lieberman, D. Peer (2020)
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyScience Advances, 6
-
Ahmed Elaswad, K. Khalil, David Cline, P. Page-McCaw, Wenbiao Chen, M. Michel, R. Cone, R. Dunham (2018)
Microinjection of CRISPR/Cas9 Protein into Channel Catfish, Ictalurus punctatus, Embryos for Gene Editing.Journal of visualized experiments : JoVE, 131
-
Jared Carlson-Stevermer, Amr Abdeen, Lucille Kohlenberg, Madelyn Goedland, Kaivalya Molugu, Meng Lou, Krishanu Saha (2017)
Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editingNature Communications, 8
-
Gerald Schwank, B. Koo, Valentina Sasselli, J. Dekkers, Inha Heo, T. Demircan, Nobuo Sasaki, S. Boymans, E. Cuppen, C. Ent, E. Nieuwenhuis, J. Beekman, H. Clevers (2013)
Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.Cell stem cell, 13 6
-
Brett Sansbury, Amanda Hewes, E. Kmiec (2019)
Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repairCommunications Biology, 2
-
A. Hendel, R. Bak, Joseph Clark, A. Kennedy, D. Ryan, Subhadeep Roy, I. Steinfeld, Benjamin Lunstad, R. Kaiser, Alec Wilkens, R. Bacchetta, A. Tsalenko, D. Dellinger, L. Bruhn, M. Porteus (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cellsNature Biotechnology, 33
-
D. Rodriguez-Rodriguez, R. Ramirez-Solis, M. Garza-Elizondo, María Garza-Rodríguez, H. Barrera-Saldana (2019)
Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)International Journal of Molecular Medicine, 43
-
Kunwoo Lee, M. Conboy, Hyo Park, F. Jiang, Hyun Kim, M. DeWitt, Vanessa Mackley, K. Chang, Anirudh Rao, Colin Skinner, Tamanna Shobha, Melod Mehdipour, Hui Liu, Wen-chin Huang, F. Lan, Nicolas Bray, Song Li, J. Corn, K. Kataoka, J. Doudna, I. Conboy, N. Murthy (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repairNature biomedical engineering, 1
-
Roland Vergilino, Shannon Eagle, T. Crease, F. Dufresne (2014)
Impact of ploidy level on the distribution of Pokey element insertions in the Daphnia pulex complexMobile DNA, 5
-
M. Daniel, D. Astruc (2004)
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.Chemical reviews, 104 1
-
M. Kotterman, T. Chalberg, D. Schaffer (2015)
Viral Vectors for Gene Therapy: Translational and Clinical Outlook.Annual review of biomedical engineering, 17
-
AC Komor, AH Badran, DR Liu (2017)
CRISPR-based technologies for the manipulation of eukaryotic genomes (vol 168, pg 20, 2017)Cell, 169
-
Wenning Qin, S. Dion, Peter Kutny, Yingfan Zhang, A. Cheng, Nathaniel Jillette, A. Malhotra, A. Geurts, Yi-Guang Chen, Haoyi Wang (2015)
Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of NucleaseGenetics, 200
-
P. Rouet, F. Smih, M. Jasin (1994)
Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease.Molecular and cellular biology, 14 12
-
Bin Li, Weiyu Zhao, Xiao Luo, Xinfu Zhang, Chenglong Li, C. Zeng, Yizhou Dong (2017)
Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiencyNature biomedical engineering, 1
-
K. Makarova, D. Haft, R. Barrangou, Stan Brouns, E. Charpentier, P. Horvath, S. Moineau, F. Mojica, Y. Wolf, A. Yakunin, J. Oost, E. Koonin (2011)
Evolution and classification of the CRISPR–Cas systemsNature Reviews Microbiology, 9
-
Xiaoyu Xu, Oliver Koivisto, Chang Liu, Jun-Nian Zhou, Mitro Miihkinen, Guillaume Jacquemet, Daqi Wang, J. Rosenholm, Y. Shu, Hongbo Zhang (2020)
Effective Delivery of the CRISPR/Cas9 System Enabled by Functionalized Mesoporous Silica Nanoparticles for GFP‐Tagged Paxillin Knock‐InAdvanced Therapeutics, 4
-
Ophir Shalem, Neville Sanjana, E. Hartenian, Xi Shi, David Scott, T. Mikkelsen, D. Heckl, B. Ebert, D. Root, J. Doench, Feng Zhang (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human CellsScience, 343
-
T. Horii, Yuji Arai, Miho Yamazaki, S. Morita, M. Kimura, M. Itoh, Yumiko Abe, I. Hatada (2014)
Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineeringScientific Reports, 4
-
Mohammadsharif Tabebordbar, K. Zhu, Jason Cheng, W. Chew, J. Widrick, C. Maesner, Elizabeth Wu, Ru Xiao, Fei Ran, L. Vandenberghe, G. Church, A. Wagers, Winston Yan, Le Cong, Feng Zhang (2016)
In vivo gene editing in dystrophic mouse muscle and muscle stem cellsScience, 351
-
Danny Halim, Michael Wilson, Daniel Oliver, E. Brosens, J. Verheij, Yu Han, V. Nanda, Qing Lyu, M. Doukas, H. Stoop, R. Brouwer, W. Ijcken, O. Slivano, A. Burns, Christine Christie, K. Bentley, A. Brooks, D. Tibboel, Suowen Xu, Z. Jin, T. Djuwantono, Wei Yan, M. Alves, R. Hofstra, J. Miano (2017)
Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and miceProceedings of the National Academy of Sciences, 114
-
D. Rath, Lina Amlinger, A. Rath, Magnus Lundgren (2015)
The CRISPR-Cas immune system: biology, mechanisms and applications.Biochimie, 117
-
P. Mali, Luhan Yang, K. Esvelt, John Aach, Marc Guell, James DiCarlo, J. Norville, G. Church (2013)
RNA-Guided Human Genome Engineering via Cas9Science, 339
-
D. Dever, R. Bak, A. Reinisch, J. Camarena, Gabriel Washington, Carmencita Nicolas, Mara Pavel-Dinu, Nivi Saxena, Alec Wilkens, Sruthi Mantri, N. Uchida, A. Hendel, A. Narla, R. Majeti, K. Weinberg, M. Porteus (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cellsNature, 539
-
J. Epinat, S. Arnould, P. Chames, Pascal Rochaix, D. Desfontaines, Clémence Puzin, Amélie Patin, A. Zanghellini, F. Pâques, E. Lacroix (2003)
A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells.Nucleic acids research, 31 11
-
J. Kaiser (2020)
Virus used in gene therapies may pose cancer risk, dog study hintsScience
-
J. Lafountaine, Kristin Fathe, H. Smyth (2015)
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.International journal of pharmaceutics, 494 1
-
F. Mojica, Chcsar Díez-Villaseñor, J. García-Martínez, E. Soria (2005)
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic ElementsJournal of Molecular Evolution, 60
-
S Konermann (2015)
583Nature, 517
-
Hao Yin, K. Kauffman, Daniel Anderson (2017)
Delivery technologies for genome editingNature Reviews Drug Discovery, 16
-
Qiang Cheng, Tuo Wei, Lukas Farbiak, Lindsay Johnson, Sean Dilliard, D. Siegwart (2020)
Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editingNature nanotechnology, 15
-
D. Burstein, Lucas Harrington, Steven Strutt, Alexander Probst, Karthik Anantharaman, B. Thomas, J. Doudna, J. Banfield (2016)
New CRISPR-Cas systems from uncultivated microbesNature, 542
-
Shyam Daya, K. Berns (2008)
Gene Therapy Using Adeno-Associated Virus VectorsClinical Microbiology Reviews, 21
-
Maarten Holkers, I. Maggio, Jin Liu, J. Janssen, F. Miselli, C. Mussolino, A. Recchia, T. Cathomen, M. Gonçalves (2012)
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cellsNucleic Acids Research, 41
-
Mauro Pistello, Guido Antonelli (2016)
Integration of the viral genome into the host cell genome: a double-edged sword.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 22 4
-
Zhibo Yu, C. Peng, Yu Luo, Jianzhi Zhu, Chen Chen, Mingwu Shen, Xiangyang Shi (2015)
Poly(γ-glutamic acid)-stabilized iron oxide nanoparticles: synthesis, characterization and applications for MR imaging of tumorsRSC Advances, 5
-
M. O’Driscoll, P. Jeggo (2006)
The role of double-strand break repair — insights from human geneticsNature Reviews Genetics, 7
-
D. Hockemeyer, Haoyi Wang, S. Kiani, Christine Lai, Q. Gao, John Cassady, G. Cost, Lei Zhang, Yolanda Santiago, Jeffrey Miller, B. Zeitler, Jennifer Cherone, Xiangdong Meng, Sarah Hinkley, E. Rebar, P. Gregory, F. Urnov, R. Jaenisch (2011)
Genetic engineering of human ES and iPS cells using TALE nucleasesNature biotechnology, 29
-
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations -
J. Bulcha, Yi Wang, Hong Ma, P. Tai, G. Gao (2021)
Viral vector platforms within the gene therapy landscapeSignal Transduction and Targeted Therapy, 6
-
J. Patra, Gitishree Das, L. Fraceto, E. Campos, M. Rodriguez-Torres, L. Acosta-Torres, L. Díaz-Torres, R. Grillo, M. Swamy, Shivesh Sharma, S. Habtemariam, Han-Seung Shin (2018)
Nano based drug delivery systems: recent developments and future prospectsJournal of Nanobiotechnology, 16
-
Xiaopei Hu, Yuting Zhang, T. Ding, Jiang-ning Liu, Hang Zhao (2020)
Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological ActivitiesFrontiers in Bioengineering and Biotechnology, 8
-
Z. Ou, X. Niu, Wenyin He, Yuchang Chen, B. Song, Yexing Xian, D. Fan, D. Tang, Xiaofang Sun (2016)
The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in MiceScientific Reports, 6
-
Shizhu Chen, Xiaohong Hao, Xing-jie Liang, Qun Zhang, Cuimiao Zhang, Guoqiang Zhou, S. Shen, Guang Jia, Jinchao Zhang (2016)
Inorganic Nanomaterials as Carriers for Drug Delivery.Journal of biomedical nanotechnology, 12 1
-
Sergey Shmakov, A. Smargon, David Scott, David Cox, N. Pyzocha, Winston Yan, Omar Abudayyeh, J. Gootenberg, K. Makarova, Y. Wolf, K. Severinov, Feng Zhang, E. Koonin (2017)
Diversity and evolution of class 2 CRISPR–Cas systemsNature Reviews Microbiology, 15
-
H. Rahimi, Marziyeh Salehiabar, Jalil Charmi, M. Barsbay, Mohammadreza Ghaffarlou, Mahdi Razlighi, S. Davaran, R. Khalilov, M. Sugiyama, H. Nosrati, Saeed Kaboli, H. Danafar, T. Webster (2020)
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 systemNano Today, 34
-
M. Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, J. Doudna, E. Charpentier (2012)
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 337
-
Marc Zuckermann, V. Hovestadt, Christiane Knobbe-Thomsen, M. Zapatka, P. Northcott, Kathrin Schramm, J. Belic, David Jones, Barbara Tschida, B. Moriarity, D. Largaespada, M. Roussel, A. Korshunov, G. Reifenberger, S. Pfister, P. Lichter, D. Kawauchi, J. Gronych (2015)
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modellingNature Communications, 6
-
D. Hockemeyer, F. Soldner, C. Beard, Q. Gao, M. Mitalipova, Russell Dekelver, George Katibah, Ranier Amora, E. Boydston, B. Zeitler, Xiangdong Meng, Jeffrey Miller, Lei Zhang, E. Rebar, P. Gregory, F. Urnov, R. Jaenisch (2009)
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleasesNature Biotechnology, 27
-
V. Cappello, L. Marchetti, P. Parlanti, S. Landi, I. Tonazzini, M. Cecchini, V. Piazza, M. Gemmi (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe DiseaseScientific Reports, 6
-
Maria Immordino, F. Dosio, L. Cattel (2006)
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInternational Journal of Nanomedicine, 1
-
DF Carlson, SC Fahrenkrug, PB Hackett (2012)
Targeting DNA with fingers and TALENsMol Ther-Nucl Acids, 1
-
S. Konermann, M. Brigham, Alexandro Trevino, J. Joung, Omar Abudayyeh, Clea Barcena, P. Hsu, Naomi Habib, J. Gootenberg, H. Nishimasu, O. Nureki, Feng Zhang (2014)
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complexNature, 517
-
LA Gilbert (2014)
647Cell, 159
-
Si-Han Wu, C. Mou, Hong‐Ping Lin (2013)
Synthesis of mesoporous silica nanoparticles.Chemical Society reviews, 42 9
-
M. Jasin, J. Haber (2016)
The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.DNA repair, 44
-
Gregory Findlay, E. Boyle, Ronald Hause, J. Klein, J. Shendure (2014)
Saturation Editing of Genomic Regions by Multiplex Homology-Directed RepairNature, 513
-
Bingchen Zhang, Bangyue Luo, Jun-Jie Zou, Pengyu Wu, Jiali Jiang, Jingqing Le, Ruirui Zhao, Lu Chen, Jing-Wei Shao (2020)
Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.ACS applied materials & interfaces
-
Meghdad Rahdar, Moira McMahon, T. Prakash, E. Swayze, C. Bennett, D. Cleveland (2015)
Synthetic CRISPR RNA-Cas9–guided genome editing in human cellsProceedings of the National Academy of Sciences, 112
-
A Elaswad, K Khalil, D Cline, P Page-McCaw, WB Chen, M Michel, R Cone, R Dunham (2018)
Microinjection of CRISPR/Cas9 Protein into Channel Catfish, Ictalurus punctatus, Embryos for Gene EditingJove-J Vis Exp, 131
-
Hao Yin, Wen Xue, Sidi Chen, R. Bogorad, Eric Benedetti, M. Grompe, V. Koteliansky, P. Sharp, T. Jacks, Daniel Anderson (2014)
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotypeNature Biotechnology, 32
-
R. Singh, H. Kim (2013)
Inorganic nanobiomaterial drug carriers for medicineTissue Engineering and Regenerative Medicine, 10
-
Tao Guo, Yili Feng, Jing-Jing Xiao, Qian Liu, Xiu-Na Sun, Ji-Feng Xiang, Na Kong, Si-Cheng Liu, Guoqiao Chen, Yue Wang, Mengmeng Dong, Z. Cai, Hui Lin, X. Cai, A. Xie (2018)
Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editingGenome Biology, 19
-
XY Xu, DB Gao, P Wang, J Chen, JX Ruan, J Xu, XF Xia (2018)
Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporationSci Rep-Uk, 8
-
Xiquan Liang, J. Potter, Shantanu Kumar, Y. Zou, R. Quintanilla, Mahalakshmi Sridharan, J. Carte, Wen Chen, Natasha Roark, S. Ranganathan, N. Ravinder, J. Chesnut (2015)
Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection.Journal of biotechnology, 208
-
E. Samaridou, J. Heyes, P. Lutwyche (2020)
Lipid nanoparticles for nucleic acid delivery: Current perspectives.Advanced drug delivery reviews
-
Shen Luo, Chi Ma, Ming-Qin Zhu, W. Ju, Yu Yang, Xu Wang (2020)
Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s DiseaseFrontiers in Cellular Neuroscience, 14
-
M. Vilariño, S. Rashid, Fabian Suchy, B. McNabb, T. Meulen, Eli Fine, Syed Ahsan, Nurlybek Mursaliyev, V. Sebastiano, S. Diab, M. Huising, H. Nakauchi, P. Ross (2017)
CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheepScientific Reports, 7
-
Fenglin Wang, Chengyao Li, Jing Cheng, Zhiqin Yuan, Huang-Tsung Chang
Environmental Research and Public Health Recent Advances on Inorganic Nanoparticle-based Cancer Therapeutic Agents -
Natalie Souza (2011)
Primer: genome editing with engineered nucleasesNature Methods, 9
-
Karima Shalaby, Mustapha Aouida, O. El‐Agnaf (2020)
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral VectorsInternational Journal of Molecular Sciences, 21
-
Bumwhee Lee, Kunwoo Lee, Shree Panda, Rodrigo Gonzales-Rojas, Anthony Chong, V. Bugay, Hyo Park, R. Brenner, N. Murthy, Hye Lee (2018)
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behavioursNature Biomedical Engineering, 2
-
J. Kulkarni, P. Cullis, R. Meel (2018)
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.Nucleic acid therapeutics, 28 3
-
J. Foo, F. Michor (2014)
Evolution of acquired resistance to anti-cancer therapy.Journal of theoretical biology, 355
-
Killian Hanlon, B. Kleinstiver, S. Garcia, M. Zaborowski, M. Zaborowski, Adrienn Volak, S. Spirig, A. Muller, Alexander Sousa, S. Tsai, N. Bengtsson, Camilla Lööv, M. Ingelsson, J. Chamberlain, D. Corey, M. Aryee, J. Joung, X. Breakefield, C. Maguire, B. György (2019)
High levels of AAV vector integration into CRISPR-induced DNA breaksNature Communications, 10
-
Guo-mei Zhang (2013)
Functional gold nanoparticles for sensing applications, 2
-
Frank Hille, E. Charpentier (2016)
CRISPR-Cas: biology, mechanisms and relevancePhilosophical Transactions of the Royal Society B: Biological Sciences, 371
-
S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. Elst, R. Muller (2008)
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.Chemical reviews, 108 6
-
B. Stoddard (2014)
Homing endonucleases from mobile group I introns: discovery to genome engineeringMobile DNA, 5
-
M. Hryhorowicz, B. Grześkowiak, Natalia Mazurkiewicz, P. Śledziński, D. Lipinski, R. Słomski (2018)
Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine FibroblastMolecular Biotechnology, 61
-
Birgit Romberg, W. Hennink, G. Storm (2007)
Sheddable Coatings for Long-Circulating NanoparticlesPharmaceutical Research, 25
-
AC Komor (2017)
559Cell, 169
-
Seuk-Min Ryu, Junseok Hur, Kyoungmi Kim (2019)
Evolution of CRISPR towards accurate and efficient mammal genome engineeringBMB Reports, 52
-
Taeho Kim, T. Hyeon (2014)
Applications of inorganic nanoparticles as therapeutic agentsNanotechnology, 25
-
Alexis Komor, A. Badran, David Liu (2017)
CRISPR-Based Technologies for the Manipulation of Eukaryotic GenomesCell, 169
-
Francisco Sánchez-Rivera, T. Jacks (2015)
Applications of the CRISPR–Cas9 system in cancer biologyNature Reviews Cancer, 15
-
Francis Pankowicz, M. Barzi, Xavier Legras, L. Hubert, Tian Mi, Julie Tomolonis, M. Ravishankar, Qin Sun, Diane Yang, M. Borowiak, Pavel Sumazin, S. Elsea, B. Bissig-Choisat, K. Bissig (2016)
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemiaNature Communications, 7
-
P. Hsu, David Scott, Joshua Weinstein, F. Ran, S. Konermann, Vineeta Agarwala, Yinqing Li, Eli Fine, Xuebing Wu, Ophir Shalem, T. Cradick, L. Marraffini, Gang Bao, Feng Zhang (2013)
DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 31
-
M. Nishita, Seung-Yeol Park, T. Nishio, Koki Kamizaki, Zhichao Wang, Kota Tamada, T. Takumi, Ryuju Hashimoto, H. Otani, G. Pazour, V. Hsu, Y. Minami (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasivenessScientific Reports, 7
-
Gaoyuan Song, Meiling Jia, Kai Chen, Xingchen Kong, B. Khattak, Chuanxiao Xie, Aili Li, Long Mao (2016)
CRISPR/Cas9: A powerful tool for crop genome editingCrop Journal, 4
-
Yanfang Fu, Jennifer Foden, Cyd Khayter, Morgan Maeder, D. Reyon, J., Keith Joung, Jeffry Sander (2013)
High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsNature biotechnology, 31
-
M. Schmeer, T. Buchholz, M. Schleef (2017)
Plasmid DNA Manufacturing for Indirect and Direct Clinical Applications.Human gene therapy, 28 10
-
Lingmin Zhang, Lingmin Zhang, Peng Wang, Qiang Feng, Nuoxin Wang, Zitian Chen, Yanyi Huang, Wenfu Zheng, Xingyu Jiang, Xingyu Jiang, Xingyu Jiang (2017)
Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapyNpg Asia Materials, 9
-
Alexis Komor, Yongjoo Kim, M. Packer, John Zuris, David Liu (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavageNature, 533
-
Suhani Vora, Marcelle Tuttle, Jenny Cheng, G. Church (2016)
Next stop for the CRISPR revolution: RNA‐guided epigenetic regulatorsThe FEBS Journal, 283
-
AC Komor (2017)
20Cell, 168
-
M Rahdar, MA McMahon, TP Prakash, EE Swayze, CF Bennett, DW Cleveland (2015)
Synthetic CRISPR RNA-Cas9-guided genome editing in human cellsP Natl Acad Sci USA, 112
-
E. Rostami, S. Kashanian, A. Azandaryani, H. Faramarzi, J. Dolatabadi, K. Omidfar (2014)
Drug targeting using solid lipid nanoparticles.Chemistry and physics of lipids, 181
-
S. Khan (2019)
Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical ApplicationMolecular Therapy. Nucleic Acids, 16
-
Hao Yin, Wen Xue, Sidi Chen, R. Bogorad, Eric Benedetti, M. Grompe, V. Koteliansky, P. Sharp, T. Jacks, Daniel Anderson (2014)
Corrigendum: Genome editing with Cas9 in adult mice corrects a disease mutation and phenotypeNature Biotechnology, 32
-
Andrew Anzalone, Peyton Randolph, Jessie Davis, Alexander Sousa, Luke Koblan, Jonathan Levy, Peter Chen, Christopher Wilson, Gregory Newby, Aditya Raguram, David Liu (2019)
Search-and-replace genome editing without double-strand breaks or donor DNANature, 576
-
D. Carlson, S. Fahrenkrug, P. Hackett (2012)
Targeting DNA With Fingers and TALENsMolecular therapy. Nucleic acids, 1
-
Christopher Nelson, Yaoying Wu, M. Gemberling, Matthew Oliver, Matthew Waller, Joel Bohning, J. Robinson-Hamm, Karen Bulaklak, Ruth Rivera, J. Collier, A. Asokan, C. Gersbach (2018)
Long-term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular DystrophyNature medicine, 25
-
B. Carter (2004)
Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective.Molecular therapy : the journal of the American Society of Gene Therapy, 10 6
-
D Hockemeyer, H Wang, S Kiani, CS Lai, Q Gao, JP Cassady, GJ Cost, L Zhang, Y Santiago, JC Miller, B Zeitler, JM Cherone, X Meng, SJ Hinkley, EJ Rebar, PD Gregory, FD Urnov, R Jaenisch (2011)
Genetic engineering of human pluripotent cells using TALE nucleasesNat Biotechnol, 29
-
FL Wang, CY Li, J Cheng, ZQ Yuan (2016)
Recent advances on inorganic nanoparticle-based cancer therapeutic agentsInt J Env Res Pub He, 13
-
D Halim, MP Wilson, D Oliver, E Brosens, JBGM Verheij, Y Han, V Nanda, Q Lyu, M Doukas, H Stoop, RWW Brouwer, WFJ van IJcken, OJ Slivano, AJ Burns, CK Christie, KLD Bentley, AS Brooks, D Tibboel, SW Xu, ZG Jin, T Djuwantono, W Yan, MM Alves, RMW Hofstra, JM Miano (2017)
Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and miceP Natl Acad Sci USA, 114
-
Hongyi Li, Yang Yang, Weiqi Hong, Mengyuan Huang, Min Wu, Xia Zhao (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospectsSignal Transduction and Targeted Therapy, 5
-
Christopher Lino, J. Harper, J. Carney, J. Timlin (2018)
Delivering CRISPR: a review of the challenges and approachesDrug Delivery, 25
-
Luke Gilbert, Max Horlbeck, Britt Adamson, Jacqueline Villalta, Yuwen Chen, E. Whitehead, Carla Guimarães, B. Panning, H. Ploegh, M. Bassik, Lei Qi, M. Kampmann, J. Weissman (2014)
Genome-Scale CRISPR-Mediated Control of Gene Repression and ActivationCell, 159
-
R. Mout, M. Ray, Gulen Tonga, Yiwei Lee, Tristan Tay, Kanae Sasaki, V. Rotello (2017)
Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.ACS nano, 11 3
- Publisher
- Springer Journals
- Copyright
- Copyright © Korean Society of Medical and Biological Engineering 2021
- ISSN
- 2093-9868
- eISSN
- 2093-985X
- DOI
- 10.1007/s13534-021-00199-4
- Publisher site
- See Article on Publisher Site
Abstract
The CRISPR-based genome editing technology has opened extremely useful strategies in biological research and clinical therapeutics, thus attracting great attention with tremendous progress in the past decade. Despite its robust potential in personalized and precision medicine, the CRISPR-based gene editing has been limited by inefficient in vivo delivery to the target cells and by safety concerns of viral vectors for clinical setting. In this review, recent advances in tailored nanoparticles as a means of non-viral delivery vector for CRISPR/Cas systems are thoroughly discussed. Unique characteristics of the nanoparticles including controllable size, surface tunability, and low immune response lead considerable potential of CRISPR-based gene editing as a translational medicine. We will present an overall view on essential elements in CRISPR/Cas systems and the nanoparticle-based delivery carriers including advantages and challenges. Perspectives to advance the current limitations are also discussed toward bench-to-bedside translation in engineering aspects.
Journal
Biomedical Engineering Letters – Springer Journals
Published: Jul 13, 2021
Keywords: CRISPR; Nanoparticle; Gene editing; Drug delivery; Gene theray